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Visualization of serotonin effects on renal vessels of rats
KARLHANS ENDLICH, REGINA KUHN, and MICHAEL STEINHAUSEN,
with the technical assistance of RUDOLF DUSSEL
I. Institute of Physiology, Universily of Heidelberg, Heidelberg, Germany
Visualization of serotonin effects on renal vessels of rats. We studied
the effects of serotoilin (5-hydroxytryptamine, 5-HT) on glomerular
blood flow (GBF) and on renal vessel diameters in the hydronephrotic
kidney and in vascular casts of normal kidneys of rats. 5-HT (60 mm
after local application of 10_s mol liter') constricted the arcuate
arteries (—10 2% to —14 2%, mean SEM), dilated the interlobular
arteries (+ 13 2%) and afferent arterioles (+ 17 3%), and decreased
GBF (—44 5%). In contrast to normal autoregulation, reduction of
renal perfusion pressure after local application of 5-HT from 118 3
mm Hg by 10 and 20 mm Hg reduced GBF by 12 2% and 23 3%,
respectively. The 5-HT2 antagonist, ritanserin (60 mm after local
application of 10 mol liter), dilated all preglomerular vessels and
increased GBF. In the presence of ritanserin, 5-HT lost nearly all
vascular effects. During infusion of 5-HT (5 min' i.v. for 20 mm)
vascular reactions were similar to those under local application. After
cyclooxygenase inhibition with indomethacin, infusion of 5-HT failed to
constrict the arcuate arteries whereas vasodilation of the small preglom-
erular vessels remained unaffected. Analyzing vascular casts of normal
kidneys we observed considerable vascular spasms and an average
vasoconstriction of the interlobar arteries of 19 9% after iv. infusion
of 5-HT. We believe that 5-HT decreases GBF by 5-HT2 receptor-
mediated constriction of the large renal vessels which are modulated by
the prostaglandin system, whereas 5-HT dilates the small preglomerular
vessels, most likely via 5-HT1-like receptors. Furthermore, our data
indicate that 5-HT impairs the myogenic component of renal autoregu-
lation in the low pressure range.
Serotonin (5-hydroxytryptamine, 5-HT) belongs to the auta-
coids functioning as a neurotransmitter and is present in the
central nervous system as well as in the periphery [1—4]. During
the last decade to the present 5-HT agonists and antagonists
have been used in the therapy of hypertension [5—8], and the
physiological role of 5-HT in circulation control is of consider-
able interest but essentially unresolved. Evidence for vasodila-
tion and vasoconstriction of renal vessels after pharmacological
doses of 5-HT is provided by several authors [9—141 in agree-
ment with receptor studies in other organs. Generally, 5-HT2
receptors act preferentially by stimulating vasoconstriction of
large arterioles, whereas vasodilation is mediated by 5-HT1-like
receptors (subgroups of receptors as well as 5-HT3 receptors
are described) [4, 15—17]. Recently, the interaction of pros-
taglandins and 5-HT has been investigated in the canine kidney
[10]. This study suggests that the vasodilator effects of 5-HT are
sensitive to indomethacin and methysergide, a 5-HT1-like and
5-HT2 receptor antagonist, whereas the dominant constrictor
mechanism, evident only after prostaglandin synthetase inhibi-
tion, is reversed by ketanserin, a 5-HT2 receptor antagonist. An
interaction between 5-HT and prostaglandins has also been
reported for the isolated perfused rat kidney [18]. In the intact
rat kidney, however, 5-HT was found to act independently of
the prostaglandin system [19]. Furthermore, by means of an-
giography vasoconstriction mediated by 5-HT2 receptors was
observed at the conduit renal arteries of the rabbit [121 and dog
[13].
Since we developed a technique to visualize the renal vascu-
lar system of rats in vivo [20, 21], we studied the effect of 5-HT
on different vascular segments of the hydronephrotic kidney
using the 5-HT2 receptor antagonist, ritanserin, as well as the
cyclooxygenase inhibitor, indomethacin. Our primary results
were: vasoconstriction of the arcuate arteries, vasodilation of
the small preglomerular vessels, and a reduction of glomerular
blood flow (GBF) during 5-HT application. These effects were
almost completely abolished by application of ritanserin which
opened up all preglomerular vessels. Cyclooxygenase inhibition
by indomethacin reduced the luminal diameter of all vessels of
the hydronephrotic kidney and decreased GBF. Under this
condition, 5-HT did not induce further vasoconstriction of the
arcuate arteries, whereas the ability to dilate the small preglom-
erular vessels remained unchanged. Furthermore, GBF did not
increase significantly. Utilizing the vascular casting technique,
we observed vasoconstriction and locally confined spasms of
the interlobar arteries during 5-HT application in the normal rat
kidney.
Methods
Induction of hydronephrosis
In this study 26 female Wistar rats (body weight ranging from
170 to 260 g) were used. Preparation and experimental proce-
dures have previously been described in detail [20]. Briefly, the
rats were anesthetized with pentobarbital (40 mg kg' i.p.,
Nembutal', Ceva, Bad Segeberg, Germany) and a permanent
ligation on the left ureter was carried out. In the next eight to
twelve weeks, a unilateral hydronephrosis developed.
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Preparation of the hydronephrotic kidney
Rats were anesthetized with thiobutalbarbital (100 mg kg'
i.p., Inactin', BYK Gulden, Konstanz, Germany). A rectal
temperature probe and a heating table were used to maintain the
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body temperature at 37°C. The trachea was intubated and the
left jugular vein was cannulated for continuous infusion of
isotonic saline (3 ml hr1) and for infusion of drugs. A catheter
was inserted into the left femoral artery for measuring systemic
blood pressure continuously.
The kidney was exposed by a left subcostal flank incision and
split carefully along the greater curvature with a thermal
cautery. The ventral half of the kidney was sutured to a
semicircular-shaped wire frame. Blood flow and innervation
remained intact after this preparation. The wire frame with the
fixed and spread kidney was placed in a Plexiglas chamber
suitable for in vivo transillumination microscopy. The entry of
the renal hilus into the chamber was sealed with silicon grease.
The chamber was filled with 50 ml of an isotonic, isocolloidal
solution (HaemaccelR, Behring, Marburg, Germany). By means
of a feedback control system, the tissue bath was kept at a
constant temperature of 37°C. After the preparation, each
kidney was allowed to adapt to the tissue bath conditions for
one hour before the experiments were begun.
In some experiments, a ligature was tied around the abdom-
inal aorta above the renal arteries to lower renal perfusion
pressure. The ligature could be tightened gradually with a
microscrew for controlled reduction of downstream pressure.
Microscopy
The split hydronephrotic kidney was visualized with a Leitz
Ultropac objective UO-55 (water immersion). The microscopi-
cal image was recorded with a television camera and a video-
tape recorder on a calibrated monitor. The luminal vessel
diameters were measured directly from the monitor, and the in
vivo diameters were calculated using the magnification param-
eters (linear magnification about 3000-fold). Diameter changes
of 1 m or less could be measured with this magnification. To
assess renal blood flow in each kidney, a dye bolus (3%
lissamine green) was injected into the jugular vein. A dye arrival
time at a selected glomerulus of 2.5 seconds or less was
considered to represent an adequate tissue perfusion, based on
a similar procedure carried out on normal rat kidneys.
Renal vascular segments
Measurements of the following vessel segments were carried
out, the vessels being identified according to the branching
pattern of the vessels from the selected cortical glomerulus: (1)
proximal arcuate artery (near the interlobar artery), (2) distal
arcuate artery (near the interlobular artery), (3) proximal inter-
lobular artery (near the arcuate artery), (4) distal interlobular
artery (near the afferent arteriole), (5) proximal cortical afferent
arteriole (near the interlobular artery), (6) distal cortical afferent
arteriole (at the narrowest segment before entering the glomer-
ulus), (7) proximal cortical efferent arteriole (within 50 tm after
leaving the glomerulus), (8) distal cortical efferent arteriole
(near the welling point).
Glomerular blood flow
GBF was determined in the efferent arteriole by a red blood
cell velocity tracking correlator (Model 102B, 1PM, San Diego,
California, USA) [22]. Two photodiodes obtained photometric
signals from the moving blood cells. The average time delay
between similar events in upstream and downstream signals
indicates the transit time the cells need to traverse the inter-
diode space. GBF was calculated from the measured red cell
velocity, from the vessel diameter assuming a circular cross
section, and from a constant factor of 0,77 correcting for the
Fahraeus effect [23].
Experimental protocol
In the following, specified concentrations for locally applied
drugs refer to the final concentration of the drug in the tissue
bath. Every protocol started with a control period. Each
protocol was made up of several periods during which systemic
blood pressure, GBF, and vascular diameters were measured.
At the end of each protocol 10—6 mol liter1 acetyicholine
(Serva, Heidelberg, Germany) and 10 mol ' liter nitroprus-
side (Merck, Darmstadt, Germany) were locally applied to
confirm vascular reactivity.
In the first series (N = 7), 10_s mol liter1 5-HT (5-HT
creatinine sulfate, Serva) were added to the tissue bath. Mea-
surements were performed after 10, 20, 30, 45, and 60 minutes.
Seventy minutes after the local application of 5-HT, renal
perfusion pressure was reduced by two to three steps. Each
step in which renal perfusion pressure was reduced by 10 mm
Hg lasted for about six minutes. Measurements were performed
in a stable state five minutes after the pressure reduction.
In the second series (N = 8)10—6 mol liter' of the 5-HT2
receptor antagonist ritanserin (Janssen, Beerse, Belgium) were
locally applied. Measurements were performed after 10, 20, 30,
45, and 60 minutes.
The third series of experiments (N = 5) was done to test the
effects of 5-HT after 5-HT2 receptor blockade. To this end, 10_6
mol liter' ritanserin were given first and after 60 minutes
10_s mol liter' 5-HT were added to the tissue bath. Measure-
ments were performed 30 and 60 minutes after each application.
In the fourth series (N = 5) the effects of intravenously
infused 5-HT and a possible interaction of 5-HT with the
prostaglandin system were studied. First, 5-HT was intrave-
nously infused for 20 minutes at a constant rate of 5 tg mine
(1.2. 10_8 mol min) dissolved in 37.5 jsl min. Measure-
ments were done 10 and 20 minutes after the beginning of the
infusion. The next measurement was performed 30 minutes
after the infusion stop. Forty minutes after the infusion stop, 1
mg ' of the cyclooxygenase inhibitor indomethacin (Sig-
ma, Deisenhofen, Germany) was intravenously injected as a
bolus followed by a continuous infusion for 60 minutes of 1/60
mg kg' min indomethacin dissolved in 25 d min'.
Measurements were performed 10 and 60 minutes after the start
of the infusion. Immediately after the indomethacin infusion a
second infusion of 5-HT was started with the identical protocol
as the first one.
Preparation of casts
To study the effects of 5-HT on the interlobar arteries in the
normal kidney, casts of the kidneys of twelve female Wistar rats
weighing 180 to 260 g were prepared. The animals were anes-
thetized with 100 mg kg1 thiobutalbarbital i.p., tracheoto-
mized, and the left jugular vein was cannulated. The abdominal
aorta was exposed by a median abdominal incision and a
catheter was inserted in the aorta caudal to the renal arteries in
a retrograde direction for measuring systemic blood pressure
continuously and for the application of various perfusates.
In six rats, 5-HT was intravenously infused for five minutes at
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Table 1. Control values of diameters, GBF, blood pressure and body weight (mean sEM)
Series 1
(N=7)
Series 2
(N=8)
Series 3(N=5)
Series 4
(N=6)
Arcuate artery proximal sm 53.5 3.5 67.4 4.5 69.6 5.6 71.5 3.2
Arcuate artery distal un 37.6 3.3 41.9 1.5 47.5 3.4 45.7 4.0
Interlobular artery proximal J.tm 23.6 0.9 26.9 1.0 26.5 1.9 27.6 1.1
Interlobular artery distal ,m 12.8 0.6 14.0 0.9 12.8 0.4 13.6 1.2
Afferent arteriole proximal 1am 8.4 0.5 10.4 0.9 9.7 0.4 10,6 0.4
Afferent arteriole distal un 7.2 0.5 8.3 0.7 7,9 0,4 8.7 0.9
Efferent arteriole proximal un 10.2 0.5 10.7 1.4 10.8 1.1 11.0 0.8
Efferent arteriole distal m 15.8 1.1 17.4 1.0 14.6 1.0 15.5 1.3
GBF nl min1 40.2 6.1 46.7 5.9 53.0 7.5 63.3 11.0
Blood pressure mm Hg 107.9 3.1 108.8 3.9 105.0 4.5 105.8 2.4
Body weight g 204.3 6.1 230.6 5.9 224.0 15.2 215.0 2.2
a rate of 4 g min' and in one rat at a rate of 10 min'.
As controls, five rats were infused with isotonic saline only (50
l min1 for 5 mm). Prior to the infusion period all rats
received 1.5 ml (7500 IU) heparin (Braun Melsungen, Melsun-
gen, Germany). Immediately after the infusion period the vena
cava was cut open, the aorta was clamped above the renal
arteries, and pressure-controlled perfusion fixation was begun
through the aortic catheter with 20 ml 1.5% glutaraldehyde in
0.1 M phosphate and 0.1% cacodylate buffer at a temperature of
37°C. Thereafter, Batson's no. 17 casting resin (Polysciences,
Warrington, Pennsylvania, USA) was injected through the
aortic catheter. The resin was prepared using the proportions of
4:1:0.1 for monomer, catalyst, and promoter, respectively, with
red pigment added. After the resin had hardened, the left kidney
was removed and placed in 40% potassium hydroxide for
digestion of the tissue. The casts were then rinsed thoroughly
with distilled water and examined by light microscopy.
Vessel morphometry
The microscopical image of the casts was recorded with a
video camera, digitized, and interactively measured with a
digital image processing board (MVP-AT, Matrox, Dorval,
Quebec, Canada). The interlobar arteries were identified ac-
cording to their branching pattern. Two to four arteries per cast
were selected at random for the measurement. Each interlobar
artery was divided into several segments along which the
vascular diameters remained fairly constant. For each segment
the diameter and the length were determined. To quantify the
vasoconstriction induced by 5-HT, we calculated an average
diameter for each vessel by weighting each segmental diameter
with the segment length. Only vessels longer than 7 mm and
their segments up to a distance of 7 mm from the origin of the
artery were used to suppress the dependence of the average
diameter from the individual vessel length. The average vessel
diameters in each animal were combined to a mean diameter per
animal.
Statistics
Results are given as mean SEM. Changes of vascular
diameters and GBF are given as percent changes from the
control value. The statistical significance of multiple interven-
tions was calculated by analysis of variance and a post-hoc
t-test. The mean diameters of the interlobar arteries per animal
measured in the kidney casts were tested for statistically
significant difference by use of the non-parametric permutation-
test of Pitman. Values of P < 0,05 were considered to be
significant.
Results
The control values of the vessel diameters, GBF, mean
arterial pressure, and body weight are summarized in Table 1.
Series 1
In the first series of experiments (N = 7) 5-HT caused a
time-dependent decrease of GBF (Fig. 1). Ten minutes after
local application of lO_8 mol liteC1 5-HT a reduction of GBF
by 13 3% was observed, whereas 60 minutes later GBF had
decreased to 56 5% of the control value. In some additional
experiments we continued the measurements up to 120 minutes
after local 5-HT application without observing further changes.
Parallel to the changes of GBF the luminal diameters also
changed time-dependently (Fig. 2). Ten minutes after 5-HT
Time, minutes
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Fig. 1. Percent changes of GBF versus time after local application of
1O mol liter' 5-HT (series 1). N = 7; data are mean SEM. * P <
0.05 vs. control; ° P < 0.05 vs. previous value.
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control
Renal perfusion pressure, mm Hg
Fig. 2. Percent changes of renal vascular
diameters 10 and 60 minutes after local
application of io mol liter' 5-HT (series
1). N = 7; data are mean SEM. * P < 0.05
vs. control; 0P < 0.05 vs. 10 mm.
Preglomerular: (1) arcuate arteries-proximal;
(2) arcuate arteries-distal; (3) interlobular
arteries-proximal; (4) interlobular arteries-
distal; (5) afferent arterioles-near interlobular
arteries; (6) afferent arterioles-near glomeruli.
Postglomerular: (7) efferent arterioles-near
glomeruli; (8) efferent arterioles-near welling
point.
application only the proximal arcuate arteries showed a slight
luminal diameter reduction. Sixty minutes after local 5-HT
application the proximal and distal arcuate arteries had con-
stricted by 14 2 and 10 2%, respectively, whereas the distal
interlobular arteries and the afferent arterioles near the inter-
lobular arteries had dilated by the same magnitude (+13 2%
and + 17 3%, respectively). The efferent arterioles were
narrowed to a negligible extent only near the welling points.
Reduction of renal perfusion pressure by clamping the aorta
70 minutes after local application of 5-HT led to a simultaneous
reduction of GBF (Fig. 3). In contrast to the usually maintained
autoregulation of GBF in the hydronephrotic kidney [241,
reduction of renal perfusion pressure from an initial value of 118
3 mm Hg by 10 and 20mm Hg caused GBF to fall by 12 2%
and 23 3%, respectively, in the presence of 5-HT. In
accordance with this result renal perfusion pressure reduction
induced no autoregulative vasodilation.
Series 2
In the second series of experiments (N = 8) local application
of 106 mol liter' of the 5-HT2 receptor antagonist ritanserin
increased GBF also in a time-dependent manner (Fig. 4). In this
series nearly all preglomerular vessels dilated significantly
already 10 minutes after local ritanserin application (Fig. 5),
After 60 minutes the luminal diameters had increased by 8 to
21%. The diameters of the efferent arterioles remained un-
changed.
Series 3
In the third series of experiments (N = 5) the effect of 5-HT
after application of ritanserin (both applied locally) was ob-
served (Fig. 6). Under this condition 5-HT evoked neither
dilation nor constriction in any vessel with the exception of the
A After 10 mm B 60 mm
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-=-
4 5
/1 78
0
*
0
1
LJ45
6
T8/1
a)0)C
C.)
a)
E
0
000
.0
Ca
a)
E00
1 x 10 mol liter1 Serotonin in bath
+20 -
+10 -
0-
—10 -
+10
0
—10
—20
—30
—40
—50
0 40 60 80 100 120
Fig. 3. Percent changes of GBF to reduction
of renal perfusion pressure 70 minutes after
local application of 10_s mol !iter' 5-HT
(series 1). The curve of each animal is
represented by a different symbol and a thin
line. The bold line corresponds to control
conditions (values are taken from [24]). Note
the immediate fall of GBF in response to renal
perfusion pressure reduction during 5-HT. N
= 6; data are mean SEM.
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proximal arcuate artery which constricted by 4 1%. GBF
decreased by 17 5%.
Series 4
In the fourth series of experiments (N = 6) we tested the
effect of 5-HT before and after indomethacin treatment. In this
series 5-HT was infused intravenously for 20 minutes each time
at a dose of 5 g min1 dissolved in 37.5 d min. As shown
in Figure 7A the pattern of renal vascular diameter changes is
very similar compared to that 60 minutes after local 5-HT
application (cf. Fig. 2). Vasoconstriction of the proximal arc-
uate arteries (—25 4%) is combined with vasodilation of the
distal interlobular arteries (+28 7%) and the afferent arteri-
oles near the interlobular arteries (+24 5%). Likewise, GBF
was reduced in a very similar manner compared to local
application (cf. Fig. 1).
Thirty minutes after the stop of the first 5-HT infusion GBF
and the vessel diameters of the arcuate arteries returned to their
initial values, whereas the distal interlobular arteries and the
afferent arterioles near the interlobular arteries did not reach
their control values (+ 10 3% and + 10 2%, respectively).
Indomethacin induced pre- and postglomerular vasoconstric-
tion in our preparation ranging from —8% to — 17%. Accord-
ingly, GBF fell by —35 5%.
Under cyclooxygenase inhibition the second 5-HT infusion
failed to constrict the arcuate arteries (Fig. 7B). However, the
pattern of vasodilation of the other preglomerular vessels was
not affected by the pretreatment with indomethacin. Besides,
the diameter of the efferent arterioles near the welling points
increased by 15 3%. GBF did not significantly change.
Mean arterial blood pressure (measured continuously in the
femoral artery) did not show any significant changes during
local application of drugs (series 1 to 3) with the exception of a
slight decrease from the initial value of 109 4 mm Hg to 104
4 mm Hg after 60 minutes local application of ritanserin.
In the fourth series of experiments mean arterial blood
pressure fell from 106 2 mm Hg under control conditions to 93
3 mm Hg 20 minutes after beginning the first 5-HT infusion,
and rose again 30 minutes after the end of the 5-HT infusion to
101 3 mm Hg. Twenty minutes after starting the second 5-HT
infusion mean arterial pressure equaled 91 7 mm Hg which
did not significantly differ from 103 5 mm Hg, the value at the
end of the indomethacin infusion.
Vascular casts
Figure 8a shows the cast of a normal rat kidney. 5-HT infused
intravenously at a rate of 4 g min for five minutes induced
a visible vasoconstriction of the large renal arteries as well as
locally confined spasms (Fig. 8b). At a rate of 10 g min'
(Fig. 8c) spasms occurred along considerable distances reduc-
ing the luminal diameter to almost zero. Thus, neither a
complete filling nor a proper preparation of the arterial tree was
possible.
The vascular casts obtained under control conditions and
after five minutes infusion of 5-HT at a rate of 4 jsg min were
quantitatively evaluated. To this end, the mean diameter as well
as the maximum and minimum diameter of the interlobar
arteries were plotted versus the distance from the origin of the
artery (Fig. 9). The step-like changes of the diameters were
caused by the quantization error of the measurement, by abrupt
changes of the vessel caliber at branching points, and by spasms
after 5-HT application. There was a large anatomical variability
among the interlobar arteries of the control animals. Neverthe-
less, the diameter of each interlobar artery generally decreased
from an initial value of about 300 sm down to about 150 m.
Furthermore, the effects of 5-HT on the interlobar arteries
conspicuously varied within one animal as well as among the
animals. The mean length of the interlobar arteries was 9130
510 jim in the control group (5 animals, 12 interlobar arteries)
and 7870 330 jim in the group receiving 5-HT (6 animals, 19
interlobar arteries). The mean diameter (as defined in Methods)
of the interlobar arteries was 245 16 p.m in the control group
(5 animals, 11 interlobar arteries), whereas it was reduced by 19
9% to 199 17 p.m after infusion of 5-HT (6 animals, 16
interlobar arteries).
Discussion
During local as well as intravenous application of 5-HT we
observed vasoconstriction of the arcuate arteries, vasodilation
of the interlobular arteries and of the afferent arterioles, and a
reduction of GBF in the hydronephrotic kidney. For the
present, it seems reasonable to assume a similar action of
5-HT1-like and 5-HT2 receptors in the kidney as in other organs
which is supported by several studies [9—141. Therefore, the
vasoconstriction of the large renal vessels should be mediated
predominantly by 5-HT2 receptors and the vasodilation of the
small preglomerular vessels by 5-HT1-like receptors. In addi-
tion, a part of the vasodilation may be caused by autoregulation
in response to the increased pressure drop along the large
arteries. Since the constriction of the large vessels is of the
same magnitude compared to the vasodilation of the small
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Fig. 4. Percent changes of GBF versus time after local application of
10—6 mol liter' ritanserin (series 2). N = 8; data are mean saM. *
<0.05 vs. control; ° P < 0.05 vs. previous value.
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vessels, the vessels upstream to the arcuate arteries which are
not routinely accessible by our technique must be constricted
during 5-HT application to account for the reduction in GBF.
For the normal kidney, we were able to measure such a
diameter reduction of the interlobar arteries in the kidney casts.
Since in the hydronephrotic kidney the vascular resistance of
the large vessels (arcuate and interlobar arteries) is nearly twice
that of the small vessels (interlobular arteries and afferent
arterioles) [25] the reduction of GBF is in good agreement with
the observed vascular reactions.
During intravenous infusion of 5-HT the vascular effects
reached a stable state within a few minutes whereas during local
application a stable state was reached after one hour. This
difference may be caused by long diffusion distances to the large
vessels relevant to locally applied substances. Furthermore,
intravenously applied substances approach the vascular wall
from intraluminal sites via the endothelium whereas locally
applied substances preferentially act on the vascular wall from
extraluminal sites. In the case of intra- and extraluminal appli-
cation of 5-HT an asymmetry of the contractile response of
isolated arteries has indeed been reported [26, 27]. This asym-
metry might be caused, at least in part, by the endothelium as
there are indications that the endothelium is involved in the
mediation of the vascular effects of 5-HT [4, 27,281. However,
the ability of 5-HT to induce renal vasodilation via endothelial
receptors is controversial [14, 291. In contrast to the effects of
Fig. 5. Percent changes of renal vascular
diameters 10 and 60 minutes after local
application of 1O mol liter' ritanserin
(series 2). N = 8; data are mean SEM. *
<0.05 vs. control; 0 P < 0.05 vs. 10 mm.
Preglomerular: (1) arcuate arteries-proximal;
(2) arcuate arteries-distal; (3) interlobular
arteries-proximal; (4) interlobular arteries-
distal; (5) afferent arterioles-near interlobular
arteries; (6) afferent arterioles-near glomeruli.
Postglomerular: (7) Efferent arterioles-near
glomeruli; (8) efferent arterioles-near welling
point.
5-HT local application of angiotensin II constricts the small pre-
and postglomerular vessels of the hydronephrotic kidney within
a few minutes [30].
Ritanserin is known as a selective 5-HT2 receptor antagonist
[31]. During local application of ritanserin all preglomerular
vessels dilated. Therefore, an endogenous tonus of 5-HT should
be present in the hydronephrotic kidney. By that, the dilation of
the large arteries is due to the blockade of 5-HT2 receptors.
Concerning the small vessels, the interpretation of their dilation
is not straightforward. On the one hand, blockade of 5-HT2
receptors could lead to a redistribution of endogenous 5-HT to
5-HT1-like receptors. On the other hand, the small vessels may
additionally possess 5-HT2 receptors. This assumption is able
to explain the vasodilation of the small vessels by combining
blockade of the 5-HT2 receptors and redistribution of 5-HT.
During 5-HT application, the vasodilation of the small vessels
remains still plausible since the autoregulative and 5-HT1-
induced vasodilation should exceed a 5-HT2-mediated constric-
tion.
During ritanserin application 5-HT did not exhibit any vas-
cular effects with the exception of a slight constriction of the
proximal arcuate arteries and a moderate reduction of GBF.
Therefore, the 5-HT2 receptor-mediated constriction of the
large arteries is almost completely blocked by ritanserin. On the
other hand the 5-HT1-like receptor-mediated dilation of the
small vessels should not be affected by the presence of ritan-
serin at first sight. However, the inefficacy of 5-HT seems to be
plausible for two reasons. First, the small vessels were already
dilated up to 20% by the application of ritanserin which reduces
the available dilator capacity. Second, the 5-HT1-like receptors
could already be completely stimulated due to the redistribution
of 5-HT discussed above.
Besides its direct action on vascular smooth muscle, 5-HT is
also known to induce vasodilation by 5-HT1-like receptor-
mediated inhibition of noradrenaline release from presynaptic
terminals of postganglionic sympathetic nerves [41. a-Adrener-
gic blockade by phentolamine and /3-adrenergic blockade by
propranolol have no vascular effects in our hydronephrotic
kidney preparation [32]. Therefore, the 5-HT-induced dilation
of the small preglomerular vessels does not appear to be caused
by inhibition of noradrenaline release. It is further unlikely that
5-HT constricts the large vessels indirectly by an increased
release of noradrenaline from sympathetic nerve terminals,
since ritanserin, which possesses low in vitro and almost no in
vivo a1-affinity [33], is able to block the 5-HT-induced vasocon-
striction. Moreover, an unaffected vascular response to 5-HT
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1 x 10 mol . liter1 Serotonin in bath (60 mm) after
1 x 10 mol . liter-1 Ritanserin in bath (60 mm)
Fig. 6. Percent changes of renal vascular diameters 60 minutes after
local application of 5-HT (10—8 mol liter') given 60 minutes after
local application of ritanserin (10—6 mol liter') versus ritanserin only
(series 3). N = 5; data are mean SEM. * P < 0.05 vs. I x 10-6
mol liter ritanserin 60 mm in bath.
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Fig. 7. Percent changes of renal vascular
diameters and GBF during intravenous
infusion of 5-HT (5 jsg min' for 20 mm)
before and after treatment with indomethacin
(1 mg kg' i.v. for 60 mm after bolus
injection of 1 mg kg' i.v.; series 4). N 6;
data are mean SEM. A. GBF = —50.9
39* * p < 0.05 vs. control. B. GBF = +29.9
18.9°. * P < 0.05 vs. indomethacin (60
mm); P < 0.05 vs. serotonin before
indomethacin.
Fig. 8. Vascular casts of the normal rat kidney. (a) control; (b) intravenous infusion of 20 g 5-HT inS mm; (c) intravenous infusion of 50 sg 5-HT
in 5 mm. Note the incomplete filling and the multiple fragments in (c) which were due to vascular spasms.
after a- as well as a-blockade was demonstrated in the cremas-
ter muscle of the rat [17].
During local application of 5-HT autoregulation was abol-
ished in our kidney preparation. We observed the same loss of
autoregulation after vasodilation by calcium antagonists [34].
Apart from a direct action of 5-HT on the contractility of
vascular smooth muscle, the responsiveness of the small ves-
sels to autoregulative stimuli could already be exhausted due to
the constriction of the large vessels acting as an autoregulative
stimulus. By this assumption, renal perfusion pressure reduc-
tion would result in an immediate fall of GBF since autoregu-
lation is predominantly mediated by vasodilation of the small
vessels [35]. As we only decreased renal perfusion pressure in
these experiments we cannot exclude that autoregulation was
maintained at higher pressures.
For the rat, 5-HT and direct agonists are known to increase
renal vascular resistance in conscious [36, 37] or anesthetized
animals [19] as well as in the isolated perfused kidney prepara-
tion [9, 11, 181. Using selective 5-HT2 receptor agonists and
antagonists, the increase of renal vascular resistance was
shown to be mediated by 5-HT2 receptors [37, 38]. Lameire et
al [391 demonstrated that blockade of 5-HT2 receptors by a low
dose of Ketanserin increased the PAH clearance and enhanced
renal autoregulation in the low pressure range. From this, it
could be deduced that 5-HT impairs renal autoregulation in the
low pressure range and that the normal kidney is subject to a
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A Control canine kidney vasoconstriction is mediated by 5-HT2 receptors
and vasodilation by 5-HT1-like receptors, whereas the opposite
action of 5-HT receptors was inferred by Shoji et a! [42].
Further, we studied the effect of cyclooxygenase inhibition
on the action of 5-HT. After cyclooxygenase inhibition 5-HT
failed to constrict the large vessels and to reduce GBF. Never-
theless, the small vessels were dilated by 5-HT again. Compar-
ing the effects of 5-HT before and after cyclooxygenase inhibi-
tion the significant differences are located at the arcuate arteries
and at the efferent arterioles near the welling points. Diameter
changes of the efferent arterioles at the welling points, which
lack vascular smooth muscle cells at this segment, are of minor
relevance as they reflect only passive mechanisms. Whereas,
for the arcuate arteries, cyclooxygenase inhibition obviously
interferes with the 5-HT2 receptor-mediated vasoconstriction.
Thus, the 5-HT2 receptor-mediated vasoconstriction is depen-
dent on an intact prostaglandin system. The dilation of the small
vessels is not affected by cyclooxygenase inhibition. This
dilation appears to be solely caused by 5-HT1-like receptors,
since an autoregulative stimulus is scarcely present and the
5-HT2 receptor-mediated constriction is abolished by indo-
methacin.
Our finding that the prostaglandin system is involved in the
vasoconstrictive action of 5-HT is in line with similar findings
for the dog [10, 13], the isolated perfused rat kidney [18], and
the isolated basilar artery of the rabbit [281. Despite of this
agreement, the vasoconstriction elicited by 5-HT in our prepa-
ration was almost completely abolished by prostaglandin syn-
thetase inhibition, as it was likewise reduced in the isolated
basilar artery of the rabbit [28], while in the other studies [10,
13, 18] vasoconstriction was enhanced in the absence of pros-
taglandins. For the normal rat kidney, however, the effects of
5-HT were not affected by indomethacin [19]. Whether these
conflicting results reflect differences between species or differ-
0 1 2 3 4 5 6 7 ences between the experimental models employed remains an
open question at present.
To study the effects of 5-HT on the interlobar arteries of the
normal kidney we utilized the vascular casting technique vali-
dated in mesenteric vessels [45] and in the post-ischemic
hydronephrotic kidney [46]. After intravenous infusion of 20 g
5-HT in five minutes we found a diameter reduction of the
interlobar arteries by about 20% and spasms. After infusion of
50 g 5-HT in five minutes the large renal vessels constricted to
such a degree that neither a complete filling nor a proper
preparation was possible. These results indicate that the 5-HT2
receptor-mediated constriction of the large vessels observed in
the hydronephrotic kidney is also present in the normal kidney.
Arteriograms of the rabbit and the dog revealed the same
vascular effects of 5-HT at the renal artery and the conduit renal
arteries [12, 13]. The vasoconstrictive effect of 5-HT at the large
renal vessels was shown to be mediated by 5-HT2 receptors and
to be modulated by prostaglandins [131, supporting our results
in the hydronephrotic kidney.
Furthermore, by the quantitative analysis of the vascular
casts we are able to provide rough estimates concerning the
vascular resistance of the interlobar arteries during control
conditions and during application of 5-HT in the normal rat
kidney. If we assume the interlobar artery to be a circular
shaped tube with linearly decreasing diameter and flow from the
beginning to the end, we could calculate the pressure drop along
basal tonus of 5-HT. All these findings for the rat kidney are in
close agreement with our results.
The 5-HT2 receptor-mediated increase of renal vascular
resistance after application of 5-HT was also confirmed in the
anesthetized as well as in the conscious rabbit [12, 401. More
recently, however, contraction of the isolated renal artery of
the rabbit was found to be mediated by 5-HT1-like receptors
[41]. In anesthetized dogs intrarenal infusion of 5-HT increased
renal blood flow after an initial transient decrease [10, 42, 43],
whereas intravenously infused 5-HT caused renal blood flow to
fall in conscious dogs [44]. Moreover, Blackshear, Orlandi and
Hollenberg [10] concluded from their experiments that in the
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Fig. 9. Morphometry of the interlobar arteries during control (A) and
after intravenous infusion of 5-NT (B; 20 /sg in 5 mm) in the normal rat
kidney. The mean diameter (bold line) of the interlobar arteries as
measured in the kidney casts is plotted versus its distance from the
origin of the vessels. The range between minimum and maximum vessel
diameters is indicated by the hatched area. The blank area along the
bold line corresponds to the range of mean SEM. After infusion of
5-HT the mean diameter decreased by about 50 m and the diameter
range increased due to vascular spasms. A. Mean diameter 245 16
m. B. Mean diameter 199 17 m; P < 0.05 vs. controls.
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this vessel by integrating the infinitesimal pressure drops over
the total vessel length. The tube resistance and the pressure
drop are derived from the law of Hagen-Poiseuille and Ohm's
law, respectively. Assuming a renal blood flow of 7 ml min
and about 10 interlobar arteries which give rise to about 100
arcuate arteries, the flow at the beginning of the interlobar
artery is set to 0.7 ml min' and to 0.07 ml min at the end.
According to our measurements the diameter is about 300 sm at
the beginning decreasing to about 150 zm at the end along a
distance of about 8 mm (cf. Fig. 9). Since the macroscopic
viscosity of blood is about 4 centiPoise the viscosity in that
diameter range is set to 3 centiPoise in consideration of the
Fahraeus-Lindqvist effect. Employing these assumptions yields
the remarkable pressure drop of 18 mm Hg along the interlobar
artery. Vasoconstriction of about 20% measured during infu-
sion of 5-HT doubles the resistance of the interlobar artery.
These are only approximate values which tend to underestimate
the effects of 5-HT as the mean diameters were obtained by
averaging over spasms. Nevertheless, these data indicate that
the interlobar arteries may substantially contribute to the total
vascular resistance of the rat kidney. Thereby, the large renal
vessels should play an important role for the regulation of renal
blood flow during 5-HT application.
In conclusion, our data indicate that 5-HT decreases renal
blood flow by 5-HT2 receptor-mediated vasoconstriction of the
interlobar and arcuate arteries. This effect is modulated by the
prostaglandin system. The interlobular arteries and afferent
arterioles are vasodilated by 5-HT most probably via 5-HT1-like
receptors. Furthermore, 5-HT impairs the myogenic compo-
nent of renal autoregulation in the low pressure range.
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